| pubmed-article:9185086 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9185086 | lifeskim:mentions | umls-concept:C0019944 | lld:lifeskim |
| pubmed-article:9185086 | lifeskim:mentions | umls-concept:C0012586 | lld:lifeskim |
| pubmed-article:9185086 | lifeskim:mentions | umls-concept:C0013039 | lld:lifeskim |
| pubmed-article:9185086 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
| pubmed-article:9185086 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:9185086 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:9185086 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9185086 | pubmed:dateCreated | 1997-7-30 | lld:pubmed |
| pubmed-article:9185086 | pubmed:abstractText | The pharmacokinetic behaviour of dipyrone metabolite 4-MAA in serum was determined in seven horses of different breeds after a single intravenous dose administration. A biexponential formula was fitted to the serum concentration vs. time data. The median half-life of the elimination phase (t1/2 beta) was 4.85 h (range 5.04 h), the median volume of distribution (Vd(area)) was 1.85 L/kg (range 3.2 L/kg) and median of total clearance was 4.0 mL/min/kg (range 2.3 mL/min/kg). | lld:pubmed |
| pubmed-article:9185086 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9185086 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9185086 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9185086 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9185086 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9185086 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9185086 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9185086 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9185086 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9185086 | pubmed:issn | 0140-7783 | lld:pubmed |
| pubmed-article:9185086 | pubmed:author | pubmed-author:HapkeH JHJ | lld:pubmed |
| pubmed-article:9185086 | pubmed:author | pubmed-author:BöttcherMM | lld:pubmed |
| pubmed-article:9185086 | pubmed:author | pubmed-author:KlausA MAM | lld:pubmed |
| pubmed-article:9185086 | pubmed:author | pubmed-author:SchlingloffYY | lld:pubmed |
| pubmed-article:9185086 | pubmed:author | pubmed-author:KleinitzUU | lld:pubmed |
| pubmed-article:9185086 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9185086 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:9185086 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9185086 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9185086 | pubmed:pagination | 204-8 | lld:pubmed |
| pubmed-article:9185086 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:meshHeading | pubmed-meshheading:9185086-... | lld:pubmed |
| pubmed-article:9185086 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9185086 | pubmed:articleTitle | Pharmacokinetic study of dipyrone metabolite 4-MAA in the horse and possible implications for doping control. | lld:pubmed |
| pubmed-article:9185086 | pubmed:affiliation | Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztliche Hochschule Hannover, Germany. | lld:pubmed |
| pubmed-article:9185086 | pubmed:publicationType | Journal Article | lld:pubmed |
